 <h1>Glatiramer Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><h2>In Summary</h2><p><b>Commonly reported side effects of glatiramer include:</b> anxiety, chest pain, dyspnea, lymphadenopathy, palpitations, post-injection flare, urticaria, vasodilation, flushing, erythema at injection site, induration at injection site, inflammation at injection site, itching at injection site, and pain at injection site. <b>Other side effects include:</b> eye disease, facial edema, laryngospasm, and chills.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to glatiramer: subcutaneous solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, glatiramer may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking glatiramer:</p><p>
<i>More common</i>
</p><ul>
<li>Anxiety</li>
<li>bleeding, hard lump, hives or welts, itching, pain, redness, or swelling at the injection site</li>
<li>chest pain</li>
<li>cough or hoarseness</li>
<li>excessive muscle tone</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>feeling of warmth</li>
<li>fever or chills</li>
<li>joint pain</li>
<li>lower back or side pain</li>
<li>neck pain</li>
<li>painful or difficult urination</li>
<li>redness of the face, neck, arms, and occasionally, upper chest</li>
<li>skin rash</li>
<li>swelling or puffiness of the face</li>
<li>swollen, painful, or tender lymph glands in the neck, armpit, or groin</li>
<li>trouble breathing</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Agitation</li>
<li>bloating or swelling</li>
<li>confusion</li>
<li>difficulty with swallowing</li>
<li>feeling faint, dizzy, or lightheaded</li>
<li>headache, severe and throbbing</li>
<li>itching of the vagina or outside genitals</li>
<li>muscle aches or pain</li>
<li>pain during sexual intercourse</li>
<li>purple spots under the skin</li>
<li>red streaks on the skin</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>small lumps under the skin</li>
<li>spasm of the throat</li>
<li>strong urge to urinate</li>
<li>sweating</li>
<li>swelling of the fingers, arms, feet, or legs</li>
<li>thick, white curd-like vaginal discharge without odor or with mild odor</li>
<li>tightness in the chest</li>
<li>tingling of the hands or feet</li>
<li>trembling or shaking of the hands or feet</li>
<li>unusual weight gain or loss</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Blood in the urine</li>
<li>burning or stinging of the skin</li>
<li>continuous, uncontrolled back-and-forth or rolling eye movements</li>
<li>decreased sexual ability</li>
<li>diarrhea</li>
<li>difficulty with moving</li>
<li>ear pain</li>
<li>fast breathing</li>
<li>irritation of the mouth and tongue (thrush)</li>
<li>loss of appetite</li>
<li>menstrual pain or changes</li>
<li>painful cold sores or blisters on the lips, nose, eyes, or genitals</li>
<li>sensation of motion, usually whirling, either of oneself or of one's surroundings</li>
<li>speech problems</li>
<li>vision problems</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Abnormal vaginal bleeding or discharge</li>
<li>back pain, sudden and severe</li>
<li>bleeding gums</li>
<li>blindness</li>
<li>blurred or decreased vision</li>
<li>chest discomfort or heaviness</li>
<li>clear or bloody discharge from the nipple</li>
<li>cloudy urine</li>
<li>coughing up blood</li>
<li>dark urine</li>
<li>decreased urine output</li>
<li>difficult or frequent urination</li>
<li>dilated neck veins</li>
<li>dimpling of the breast skin</li>
<li>drowsiness</li>
<li>extreme tiredness or weakness</li>
<li>eye pain</li>
<li>gaseous stomach pain</li>
<li>general feeling of discomfort or illness</li>
<li>general tiredness and weakness</li>
<li>hair loss</li>
<li>headache</li>
<li>heartburn</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>indigestion</li>
<li>inverted nipple</li>
<li>joint swelling</li>
<li>large amount of cholesterol in the blood</li>
<li>light-colored stools</li>
<li>lump in the breast or under the arm</li>
<li>lump or swelling in the stomach</li>
<li>muscle weakness, sudden and progressing</li>
<li>nausea</li>
<li>nerve pain</li>
<li>nosebleed</li>
<li>pain or discomfort the in arms or jaw</li>
<li>paralysis</li>
<li>persistent crusting or scaling of the nipple</li>
<li>prolonged bleeding from cuts</li>
<li>puffiness or swelling of the eyelids or around the eyes, lips, or tongue</li>
<li>rapid, shallow breathing</li>
<li>recurrent fever</li>
<li>red or black, tarry stools</li>
<li>redness or swelling of the breast</li>
<li>seizures</li>
<li>sore on the skin of the breast that does not heal</li>
<li>sore throat</li>
<li>stiff neck or back</li>
<li>stomach bloating, burning, cramping, or pain</li>
<li>tearing</li>
<li>tenderness, pain, swelling, warmth, skin discoloration, and prominent superficial veins over the affected area</li>
<li>unusual tiredness or weakness</li>
<li>upper right abdominal or stomach pain</li>
<li>vomiting</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of glatiramer may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Lack or loss of strength</li>
<li>stuffy or runny nose</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Double vision</li>
</ul><p>
<!-- end subcutaneous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to glatiramer: subcutaneous kit, subcutaneous powder for injection, subcutaneous solution</i></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site erythema (43%), injection site pain (40%), injection site pruritus (27%), injection site mass (26%), injection site edema (19%)</p>
<p><b>Common</b> (1% to 10%): Injection site inflammation, injection site reaction, injection site hypersensitivity, injection site fibrosis, injection site atrophy</p>
<p><b>Uncommon</b> (0.1% to 1%): Injection site hematoma, injection site abscess, injection site hypertrophy, injection site melanosis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Vasodilation (20%), chest pain (13%)</p>
<p><b>Common</b> (1% to 10%): Palpitations, tachycardia, hypertension</p>
<p><b>Uncommon</b> (0.1% to 1%): Hypotension, midsystolic click, systolic murmur, atrial fibrillation, bradycardia, fourth heart sound, postural hypotension, varicose veins, warts, dry skin </p>
<p><b>Postmarketing reports</b>: Thrombosis, peripheral vascular disease, pericardial effusion, myocardial infarct, deep thrombophlebitis, coronary occlusion, congestive heart failure, cardiomyopathy, cardiomegaly, arrhythmia, angina pectoris<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Lymphadenopathy</p>
<p><b>Uncommon</b> (0.1% to 1%): Leukopenia, anemia, cyanosis, eosinophilia, hematemesis, lymphedema, pancytopenia, splenomegaly<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (15%)</p>
<p><b>Common</b> (1% to 10%): Vomiting, dysphagia, gastroenteritis</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry mouth, stomatitis, burning sensation on tongue, cholecystitis, colitis, esophageal ulcer, esophagitis, gastrointestinal carcinoma, gum hemorrhage, increased appetite, melena, mouth ulceration, pancreas disorder, pancreatitis, rectal hemorrhage, tenesmus, tongue discoloration, duodenal ulcer, circumoral paresthesia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (14%)</p>
<p><b>Common</b> (1% to 10%): Rhinitis, bronchitis, cough, laryngospasm, hyperventilation, hay fever</p>
<p><b>Uncommon</b> (0.1% to 1%): Asthma, pneumonia, epistaxis, hypoventilation, voice alteration</p>
<p><b>Postmarketing reports</b>: Pulmonary embolus, pleural effusion, carcinoma of lung<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Cirrhosis of the liver, cholelithiasis hepatomegaly<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (19%)</p>
<p><b>Common</b> (1% to 10%): Hyperhidrosis, pruritus, urticaria, skin disorder, eczema, herpes zoster, pustular rash, skin atrophy, warts</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry skin, skin hypertrophy, dermatitis, furunculosis, psoriasis, angioedema, contact dermatitis, erythema nodosum, fungal dermatitis, maculopapular rash, pigmentation, benign skin neoplasm, skin carcinoma, skin striae, vesiculobullous rash</p>
<p><b>Postmarketing reports</b>: Thrombocytopenia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Uncommon</b> (0.1% to 1%): Goitre, hyperthyroidism, hypothyroidism<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Vaginal candidiasis, micturition urgency, amenorrhea, hematuria, impotence, menorrhagia, suspicious Papanicolaou smear, urinary frequency, vaginal hemorrhage</p>
<p><b>Uncommon</b> (0.1% to 1%): Decreased libido, vaginitis, abortion, breast engorgement, breast enlargement, carcinoma in situ cervix, fibrocystic breast, kidney calculus, nocturia, ovarian cyst, priapism, pyelonephritis, abnormal sexual function, urethritis</p>
<p><b>Postmarketing reports</b>: Urogenital neoplasm, urine abnormality, ovarian carcinoma, nephrosis, breast carcinoma, bladder carcinoma<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity, allergic reaction, anaphylactoid reaction<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infection (30%), influenza (14%)</p>
<p><b>Common</b> (1% to 10%): Abscess</p>
<p><b>Uncommon</b> (0.1% to 1%): Cellulitis, serum sickness<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Weight gain</p>
<p><b>Postmarketing reports</b>: Hypercholesterolemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (12%)</p>
<p><b>Common</b> (1% to 10%): Chills</p>
<p><b>Uncommon</b> (0.1% to 1%): Lipoma, arthritis, muscle atrophy, bone pain, bursitis, muscle disorder, myopathy, osteomyelitis, tendon pain, tenosynovitis</p>
<p><b>Postmarketing reports</b>: Systemic lupus erythematosus (SLE), rheumatoid arthritis, generalized spasm<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Pain (20%)</p>
<p><b>Common</b> (1% to 10%): Tremor, migraine, syncope, speech disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Convulsion, hypokinesia, coma, facial paralysis, myoclonus, neuralgia, paraplegia</p>
<p><b>Postmarketing reports</b>: Hydrocephalus, myelitis, meningitis, CNS neoplasm, cerebrovascular accident, brain edema, neuralgia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Eye disorder, diplopia, visual field defect</p>
<p><b>Uncommon</b> (0.1% to 1%): Photosensitivity, dry eyes, otitis externa, ptosis, cataract, corneal ulcer, mydriasis, optic neuritis, photophobia</p>
<p><b>Postmarketing reports</b>: Glaucoma, vision loss<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Benign neoplasm of skin</p>
<p><b>Postmarketing reports</b>: Lymphoma-like reaction, acute leukemia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia (22%)</p>
<p><b>Common</b> (1% to 10%): Edema, face edema, peripheral edema</p>
<p><b>Uncommon</b> (0.1% to 1%): Aphasia, ataxia, taste loss<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Anxiety (13%)</p>
<p><b>Common</b> (1% to 10%): Nervousness, abnormal dreams, emotional lability, stupor</p>
<p><b>Uncommon</b> (0.1% to 1%): Suicide attempt, depersonalization, hallucinations, hostility, concentration disorder, manic reaction, memory impairment, paranoid reaction, psychotic depression, transient stupor<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Kidney pain, kidney calculus</p>
<p><b>Postmarketing reports</b>: Kidney failure<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_3">3. "Product Information. Copaxone (glatiramer)." Teva Pharmaceuticals USA, Kulpsville, PA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>What happens if an MS patient stops taking Copaxone?</li>
<li>How long does it take for Copaxone to be effective?</li>
<li>How does Copaxone work as treatment for multiple sclerosis?</li>
<li>How long can you take Copaxone?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about glatiramer</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>139 Reviews</li>
<li>Drug class: other immunostimulants</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Glatiramer Subcutaneous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Copaxone, Glatopa</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Sclerosis</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to glatiramer: subcutaneous kit, subcutaneous powder for injection, subcutaneous solution</i></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site erythema (43%), injection site pain (40%), injection site pruritus (27%), injection site mass (26%), injection site edema (19%)</p><p><b>Common</b> (1% to 10%): Injection site inflammation, injection site reaction, injection site hypersensitivity, injection site fibrosis, injection site atrophy</p><p><b>Uncommon</b> (0.1% to 1%): Injection site hematoma, injection site abscess, injection site hypertrophy, injection site melanosis<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Vasodilation (20%), chest pain (13%)</p><p><b>Common</b> (1% to 10%): Palpitations, tachycardia, hypertension</p><p><b>Uncommon</b> (0.1% to 1%): Hypotension, midsystolic click, systolic murmur, atrial fibrillation, bradycardia, fourth heart sound, postural hypotension, varicose veins, warts, dry skin </p><p><b>Postmarketing reports</b>: Thrombosis, peripheral vascular disease, pericardial effusion, myocardial infarct, deep thrombophlebitis, coronary occlusion, congestive heart failure, cardiomyopathy, cardiomegaly, arrhythmia, angina pectoris<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Lymphadenopathy</p><p><b>Uncommon</b> (0.1% to 1%): Leukopenia, anemia, cyanosis, eosinophilia, hematemesis, lymphedema, pancytopenia, splenomegaly<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (15%)</p><p><b>Common</b> (1% to 10%): Vomiting, dysphagia, gastroenteritis</p><p><b>Uncommon</b> (0.1% to 1%): Dry mouth, stomatitis, burning sensation on tongue, cholecystitis, colitis, esophageal ulcer, esophagitis, gastrointestinal carcinoma, gum hemorrhage, increased appetite, melena, mouth ulceration, pancreas disorder, pancreatitis, rectal hemorrhage, tenesmus, tongue discoloration, duodenal ulcer, circumoral paresthesia<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Dyspnea (14%)</p><p><b>Common</b> (1% to 10%): Rhinitis, bronchitis, cough, laryngospasm, hyperventilation, hay fever</p><p><b>Uncommon</b> (0.1% to 1%): Asthma, pneumonia, epistaxis, hypoventilation, voice alteration</p><p><b>Postmarketing reports</b>: Pulmonary embolus, pleural effusion, carcinoma of lung<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Postmarketing reports</b>: Cirrhosis of the liver, cholelithiasis hepatomegaly<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (19%)</p><p><b>Common</b> (1% to 10%): Hyperhidrosis, pruritus, urticaria, skin disorder, eczema, herpes zoster, pustular rash, skin atrophy, warts</p><p><b>Uncommon</b> (0.1% to 1%): Dry skin, skin hypertrophy, dermatitis, furunculosis, psoriasis, angioedema, contact dermatitis, erythema nodosum, fungal dermatitis, maculopapular rash, pigmentation, benign skin neoplasm, skin carcinoma, skin striae, vesiculobullous rash</p><p><b>Postmarketing reports</b>: Thrombocytopenia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Uncommon</b> (0.1% to 1%): Goitre, hyperthyroidism, hypothyroidism<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Vaginal candidiasis, micturition urgency, amenorrhea, hematuria, impotence, menorrhagia, suspicious Papanicolaou smear, urinary frequency, vaginal hemorrhage</p><p><b>Uncommon</b> (0.1% to 1%): Decreased libido, vaginitis, abortion, breast engorgement, breast enlargement, carcinoma in situ cervix, fibrocystic breast, kidney calculus, nocturia, ovarian cyst, priapism, pyelonephritis, abnormal sexual function, urethritis</p><p><b>Postmarketing reports</b>: Urogenital neoplasm, urine abnormality, ovarian carcinoma, nephrosis, breast carcinoma, bladder carcinoma<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Common</b> (1% to 10%): Hypersensitivity, allergic reaction, anaphylactoid reaction<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Infection (30%), influenza (14%)</p><p><b>Common</b> (1% to 10%): Abscess</p><p><b>Uncommon</b> (0.1% to 1%): Cellulitis, serum sickness<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Weight gain</p><p><b>Postmarketing reports</b>: Hypercholesterolemia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Very common</b> (10% or more): Back pain (12%)</p><p><b>Common</b> (1% to 10%): Chills</p><p><b>Uncommon</b> (0.1% to 1%): Lipoma, arthritis, muscle atrophy, bone pain, bursitis, muscle disorder, myopathy, osteomyelitis, tendon pain, tenosynovitis</p><p><b>Postmarketing reports</b>: Systemic lupus erythematosus (SLE), rheumatoid arthritis, generalized spasm<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Pain (20%)</p><p><b>Common</b> (1% to 10%): Tremor, migraine, syncope, speech disorder</p><p><b>Uncommon</b> (0.1% to 1%): Convulsion, hypokinesia, coma, facial paralysis, myoclonus, neuralgia, paraplegia</p><p><b>Postmarketing reports</b>: Hydrocephalus, myelitis, meningitis, CNS neoplasm, cerebrovascular accident, brain edema, neuralgia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Eye disorder, diplopia, visual field defect</p><p><b>Uncommon</b> (0.1% to 1%): Photosensitivity, dry eyes, otitis externa, ptosis, cataract, corneal ulcer, mydriasis, optic neuritis, photophobia</p><p><b>Postmarketing reports</b>: Glaucoma, vision loss<sup>[Ref]</sup></p><h3>Oncologic</h3><p><b>Common</b> (1% to 10%): Benign neoplasm of skin</p><p><b>Postmarketing reports</b>: Lymphoma-like reaction, acute leukemia<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Asthenia (22%)</p><p><b>Common</b> (1% to 10%): Edema, face edema, peripheral edema</p><p><b>Uncommon</b> (0.1% to 1%): Aphasia, ataxia, taste loss<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Anxiety (13%)</p><p><b>Common</b> (1% to 10%): Nervousness, abnormal dreams, emotional lability, stupor</p><p><b>Uncommon</b> (0.1% to 1%): Suicide attempt, depersonalization, hallucinations, hostility, concentration disorder, manic reaction, memory impairment, paranoid reaction, psychotic depression, transient stupor<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Kidney pain, kidney calculus</p><p><b>Postmarketing reports</b>: Kidney failure<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Pharmaceutical Society of Australia "APPGuide online. Australian prescription products guide online. Available from: URL: http://www.appco.com.au/appguide/default.asp."   ([2006]):</p><p id="ref_3">3. "Product Information. Copaxone (glatiramer)." Teva Pharmaceuticals USA, Kulpsville, PA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>What happens if an MS patient stops taking Copaxone?</li>
<li>How long does it take for Copaxone to be effective?</li>
<li>How does Copaxone work as treatment for multiple sclerosis?</li>
<li>How long can you take Copaxone?</li>
</ul><h2>More about glatiramer</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>139 Reviews</li>
<li>Drug class: other immunostimulants</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Glatiramer Subcutaneous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Multiple Sclerosis</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>